Physician profile

Stephanie Worrell

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tucson, AZ

NPI 1851685523

$76,931.30

in general payments reported to CMS, 2019-2025

28 companies · $16K in 2025

The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$15,500.00
Education$13,082.30
Food and Beverage$12,061.00
Travel and Lodging$10,720.68
Consulting Fee$1,420.00
Grant$1,203.95
Gift$53.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $56,345.73 2019-2025 Da Vinci Surgical System, Ion, Davinci Xi
Medtronic, INC. $5,774.61 2021-2025 Signia, Penditure, Signet
Medical Device Business Services, INC. $2,865.70 2019-2021
E.R. Squibb & Sons, L.L.C. $2,443.95 2022
Atricure, INC. $1,901.01 2022-2025 Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax
Genentech USA, INC. $1,420.00 2024 Alecensa
Ethicon US, LLC $1,348.16 2019-2023 Dermabond Prineo, Ethicon
Davol INC. $1,018.06 2019-2024 Progel Applicator Spray Tips, Phasix Mesh
Baxter Healthcare $656.74 2019-2025 Coseal, Preveleak
Depuy Synthes Sales INC. $545.68 2022-2025 Matrixrib, Zipfix, Na
Astrazeneca Pharmaceuticals LP $412.76 2021-2025 Imfinzi
Boston Scientific Corporation $386.69 2019-2023 Agile Esophageal
Becton, Dickinson and Company $335.27 2019-2024 Progel Applicator Spray Tips
Merit Medical Systems INC $220.25 2023-2025 Elation Balloon Dilator, Big60 Inflation Device, Aeromini Stent and Delivery System
Edwards Lifesciences Corporation $209.73 2024-2025 Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Bard Access Systems, INC. $181.15 2019
Kls-Martin L.P. $154.93 2019-2025
Bard Peripheral Vascular, INC. $154.14 2021
Galvanize Therapeutics, INC $122.32 2024 Aliya System
Ethicon INC. $105.95 2022
On Target Laboratories, INC $77.81 2025 Cytalux
Janssen Biotech, INC. $71.26 2021
Zimmer Biomet Holdings, INC. $55.58 2020
Dilon Technologies, INC. $47.95 2023-2024 Hemoblast Bellows
Abbott Laboratories $23.07 2022
Integra Lifesciences Corporation $20.72 2022
Nestle Healthcare Nutrition INC. $18.89 2021
Sobi, INC $13.19 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stephanie Worrell

$76,931.30

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/1070991/stephanie-worrell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.